These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 880435)

  • 1. Inhibition of dopaminergic activity in the extrapyramidal and limbic systems by gamma-acetylenic GABA [proceedings].
    Huot S; Lippert B; Palfreyman MG; Schechter PJ
    Br J Pharmacol; 1977 Jun; 60(2):264P-265P. PubMed ID: 880435
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine-acetylcholine-GABA neuronal linkages in the extrapyramidal and limbic systems.
    McGeer PL; McGeer EG; Hattori T
    Adv Biochem Psychopharmacol; 1977; 16():397-402. PubMed ID: 329651
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.
    Bartholini G; Scatton B; Worms P; Zivkovic B; Lloyd KG
    Adv Biochem Psychopharmacol; 1981; 30():119-28. PubMed ID: 6120626
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of gamma-acetylenic GABA, an enzyme-activated irreversible inhibitor of GABA-transaminase, on dopamine pathways of the extrapyramidal and limbic systems.
    Palfreyman MG; Huot S; Lippert B; Schechter PJ
    Eur J Pharmacol; 1978 Aug; 50(4):325-36. PubMed ID: 699960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functions of dopamine in the extrapyramidal and limbic systems. Clues for the mechanism of drug actions.
    Di Chiara G; Morelli M; Acquas E; Carboni E
    Arzneimittelforschung; 1992 Feb; 42(2A):231-7. PubMed ID: 1586394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs.
    Fuxe K; Hökfelt T; Ljungdahl A; Agnati L; Johansson O; Perez de la Mora M
    Med Biol; 1975 Jun; 53(3):177-83. PubMed ID: 1160412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of dopaminergic and cholinergic neurons in the extrapyramidal and limbic systems.
    Bartholini G; Stadler H; Gadea-Ciria M; Lloyd KG
    Adv Biochem Psychopharmacol; 1977; 16():391-5. PubMed ID: 18888
    [No Abstract]   [Full Text] [Related]  

  • 8. [Potential therapeutic activity of GABA-mimetic drugs in neuropsychiatry].
    Bartholini G
    Schweiz Arch Neurol Neurochir Psychiatr; 1979; 125(2):265-9. PubMed ID: 45343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function.
    Bartholini G
    Adv Biochem Psychopharmacol; 1977; 16():607-11. PubMed ID: 18902
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation of gamma-aminobutyric acid (GABA) action by inhibiting neuroglial uptake [proceedings].
    Galvan M; Brown DA
    Br J Pharmacol; 1977 Mar; 59(3):485P-486P. PubMed ID: 843723
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of substance P release from the isolated rat substantia nigra by GABA [proceedings].
    Jessell TM; Iversen LL
    Br J Pharmacol; 1977 Mar; 59(3):486P. PubMed ID: 843724
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of cocaine on extrapyramidal and limbic dynorphin systems.
    Smiley PL; Johnson M; Bush L; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):938-43. PubMed ID: 1972755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the new gamma-aminobutyric acid agonist SL 76 002 on striatal acetylcholine: relation to neuroleptic-induced extrapyramidal alterations.
    Bartholini G; Scatton B; Zivkovic B
    Adv Biochem Psychopharmacol; 1980; 24():207-13. PubMed ID: 6105775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaba blockade, dopamine and schizophrenia: experimental activation of the mesolimbic system.
    Stevens JR
    Int J Neurol; 1975; 10(1-4):115-27. PubMed ID: 1237474
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo effects of GABA uptake inhibitors on the response of cat spinal neurones to GABA analogues [proceedings].
    Curtis DR; Johnston GA; Lodge D
    Br J Pharmacol; 1977 Sep; 61(1):148P. PubMed ID: 912196
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative evaluation of evoked potentials after administration of gama-aminobutyric acid (GABA) and its structural analogues to adult rats.
    Rokyta R; Safanda J; Sobotka P
    Act Nerv Super (Praha); 1976 Jun; 18(1-2):110-1. PubMed ID: 941630
    [No Abstract]   [Full Text] [Related]  

  • 17. GABA receptor agonists and extrapyramidal motor function: therapeutic implications for Parkinson's disease.
    Bartholini G; Scatton B; Zivkovic B; Lloyd KG
    Adv Neurol; 1987; 45():79-83. PubMed ID: 3030072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents.
    Costall B; Naylor RJ
    Neuropharmacology; 1974 May; 13(5):353-64. PubMed ID: 4607196
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of the glutamate, GABA, and dopamine systems in relation to NRH-induced neurotoxicity.
    Benes FM
    Biol Psychiatry; 1995 Dec; 38(12):783-7. PubMed ID: 8750035
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of gamma-aminobutyric acid and phenibut on the central links of the vascular reflexes with chemo- and mechanoreceptors of the aorto-carotid zone].
    Kovalev GV; Morozov IS
    Biull Eksp Biol Med; 1975 Apr; 79(4):71-5. PubMed ID: 1191772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.